Cardiovascular System

NCBiotech Company Directory is a comprehensive listing of North Carolina's life science industry New search

Company Title Company Description City
Accord Healthcare Inc.

Accord Healthcare is the marketing subsidiary of Intas Pharmaceuticals, an India-based company that focuses on manufacturing generic pharmaceuticals and biosimilars for the global market.

Aegis Surgical Ltd.

AEGIS is developing a less invasive access system that facilitates percutaneous transaortic transcatheter aortic valve replacement (pTAo-TAVR).

Affinergy LLC

Affinergy develops peptide-based technologies, including diagnostic products, research tools and therapeutic drug monitoring products for use by clinicians and researchers.

Allwell Medical Corp.

Allwell Medical manufactures interventional cardiology accessories including inflation devices, coronary control injection sets, balloons and catheters.


Asklepios BioPharmaceutical (AskBio) uses adeno-associated virus (AAV) technology to develop and manufacture gene therapies for rare diseases and other genetic disorders.

Research Triangle Park
Baebies Inc.

Baebies develops and commercializes products and services based on digital microfluidics and other technology that ensure early disease detection and comprehensive diagnosis for children.

CardioEphEx LLC

CardioEphEx develops therapeutics for cardiovascular disease and heart failure. The company's research focuses on cardioprotection by targeting the Ephrin/Eph receptor signaling pathway in the heart.

CardioPharma Inc.

CardioPharma develops combinatorial products to treat cardiovascular disease.

Catalyst Medicine LLC

Catalyst Medicine designs, develops and commercializes Class 1 and Class 2 medical devices in the areas of neurology, orthopedics, cardiology and plastic surgery.

Cathtek Inc.

Cathtek develops and manufactures catheters and related accessories.

Charles River Laboratories (Morrisville)

Charles River Laboratories' Oncology Center of Excellence provides in vivo and in vitro oncology and immuno-oncology research services.

Chiesi USA Inc.

Chiesi USA, the U.S. affiliate of Chiesi Farmaceutici S.p.A, develops and commercializes products in the therapeutic areas of respiratory, cardiovascular, neonatology and cystic fibrosis.


Clinipace provides full global CRO service to pharmaceutical and biotechnology companies, working across all major therapeutic areas including oncology, gastroenterology and women's health and rare disease.

CMP Pharma Inc.

CMP develops, manufactures and commercializes specialty pharmaceuticals, focused on niche liquid and topical products that solve unmet patient needs.

Contego Medical LLC

Contego Medical develops embolic protection devices for cardiovascular and peripheral vascular procedures, designed to simplify catheter-based procedures.


Grifols manufactures and markets plasma-derived medicines to treat chronic and acute conditions in the therapeutic areas of immunology, pulmonology, hematology, thrombolytics and neurology.

Research Triangle Park
Humacyte Inc.

Humacyte develops a technology platform that isolates and grows stable investigational human tissue replacements with potential regenerative medicine, vascular and nonvascular surgery applications.

InnAVasc Medical Inc.

InnAVasc Medical designs and develops products for vascular access. The company's first technology is an arteriovenous graft (AVG) modification that facilitates graft access and safety in hemodialysis.

Kowa Research Institute Inc.

Kowa Research Institute, a division of Kowa Company Ltd., develops therapeutic drugs for the treatment of cardio-metabolic diseases such as diabetes and atherosclerosis, pain and sensory organ disorders.

Liquidia Technologies Inc.

Liquidia Technologies develops and commercializes human therapeutics for the treatment of pulmonary arterial hypertension and post-operative pain using its proprietary particle engineering technology.

MD Scientific LLC

MD Scientific developed the EndoTool Glucose Management System and is currently developing a drug to prevent kidney and heart injury from iodinated contrast agents.

Micell Technologies Inc.

Micell Technologies develops combination-product therapies for interventional cardiology. Micell markets MiStent, a drug-eluting stent, in Europe and certain other regions.

Milestone Pharmaceuticals USA Inc.

Milestone Pharmaceuticals is developing an investigational new drug intended to provide rapid-onset and short-acting treatment of paroxysmal supraventricular tachycardia (PSVT) episodes and other episodic conditions.

Momentum Research Inc.

Momentum Research manages and directs phase one through four clinical research projects and specializes in cardiovascular clinical trials management.

NanoCor Therapeutics Inc.

NanoCor Therapeutics develops an intracellular genetic protein therapy for the treatment of chronic heart failure.

Research Triangle Park
NeuroTronik Inc.

NeuroTronik develops medical technology for the treatment of acute heart failure syndrome.

Nocturnal Product Development LLC

Nocturnal Product Development provides contract design and development services for Class II and Class III medical devices. The company is also developing an ablation catheter that enables real-time visualization of ablated cardiac tissue.


NuPulseCV is developing an implantable cardiovascular left ventricular assist device to treat people suffering from congestive heart failure.

Phoenix Cardiac Devices Inc.

Phoenix Cardiac Devices is designing and developing a cardiac device to treat functional mitral valve regurgitation.

QuatroBio LLC

QuatroBio provides oversight and strategic direction to several closely held drug development companies.

SonoVascular Inc.

SonoVascular is developing a thrombolysis device for the treatment of blood clots related to deep vein thrombosis, pulmonary embolism and peripheral arterial occlusions.

Chapel Hill
SunTech Medical Inc.

SunTech Medical manufactures non-invasive blood pressure monitoring products and technology.

Tryton Medical Inc.

Tryton Medical develops and sells stent systems for the treatment of coronary artery bifurcation lesions.

United Therapeutics Corp.

United Therapeutics develops and commercializes products to treat cardiopulmonary diseases, infectious diseases and cancer.

Research Triangle Park
Vascular BioSciences Inc.

Vascular BioSciences is a biopharmaceutical company developing solutions for difficult-to-treat cardiovascular and inflammatory diseases.

Velo Bio LLC

Velo Bio is developing an orphan drug for the treatment of severe preeclampsia in pregnant women.

Veloxis Pharmaceuticals Inc.

Veloxis Pharmaceuticals is focused on the commercialization of ENVARSUS XR (tacrolimus extended-release tablets) based upon the company’s patented delivery technology, MeltDose.

Worldwide Clinical Trials Inc.

Worldwide Clinical Trials provides phase one through phase four drug development services to the pharmaceutical and biotechnology industries.

X-in8 Biologicals Corp.

X-in8 Biologicals develops technologies to prevent and treat ischemia reperfusion injury in the context of organ transplant, myocardial infarction and stroke.

Chapel Hill
Xollent Biotech Inc.

Xollent Biotech is developing a therapeutic to treat cardiovascular disease based on exosome-secreting cells.